208 related articles for article (PubMed ID: 16790324)
1. Magnesium supplementation in the treatment of dementia patients.
Ozturk S; Cillier AE
Med Hypotheses; 2006; 67(5):1223-5. PubMed ID: 16790324
[TBL] [Abstract][Full Text] [Related]
2. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
3. Memantine: pharmacological properties and clinical uses.
Kumar S
Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
[TBL] [Abstract][Full Text] [Related]
4. Memantine for dementia?
Drug Ther Bull; 2003 Oct; 41(10):73-6. PubMed ID: 14593973
[TBL] [Abstract][Full Text] [Related]
5. Treating the full spectrum of dementia with memantine.
Winblad B; Jelic V
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S41-6. PubMed ID: 12973749
[TBL] [Abstract][Full Text] [Related]
6. [The clinical relevance of memantine use].
Sobów T
Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
8. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
10. [Advanced dementia in Alzheimer's disease and memantine].
Alberca R
Rev Neurol; 2005 Feb 1-15; 40(3):173-9. PubMed ID: 15750904
[TBL] [Abstract][Full Text] [Related]
11. Memantine: update on the current evidence.
Möbius HJ
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S47-54. PubMed ID: 12973750
[TBL] [Abstract][Full Text] [Related]
12. [Memantine].
Molinuevo JL
Neurologia; 2003 Jun; 18(5):255-61. PubMed ID: 12768511
[TBL] [Abstract][Full Text] [Related]
13. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists.
Muir KW
Curr Opin Pharmacol; 2006 Feb; 6(1):53-60. PubMed ID: 16359918
[TBL] [Abstract][Full Text] [Related]
14. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
Lipton SA
Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
[TBL] [Abstract][Full Text] [Related]
16. [The action of memantine on the cognitive disorders of patients with dementia: reflections following two years' experience in Spain].
Robles-Bayón A
Rev Neurol; 2006 Mar 1-15; 42(5):288-96. PubMed ID: 16538592
[TBL] [Abstract][Full Text] [Related]
17. Memantine (Namenda) for moderate to severe Alzheimer's disease.
Ables AZ
Am Fam Physician; 2004 Mar; 69(6):1491-2. PubMed ID: 15053415
[No Abstract] [Full Text] [Related]
18. Memantine in the treatment of dementia.
Maggiore C; Locatelli L; Grandi FC; Pizzolato G;
Neuroepidemiology; 2007; 28(2):118-9. PubMed ID: 17409774
[No Abstract] [Full Text] [Related]
19. Stroke, Alzheimer's patients may benefit from AIDS dementia drug.
Dent Today; 1997 Feb; 16(2):29. PubMed ID: 9560599
[No Abstract] [Full Text] [Related]
20. In vitro galantamine-memantine co-application: mechanism of beneficial action.
Zhao X; Marszalec W; Toth PT; Huang J; Yeh JZ; Narahashi T
Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]